bucladesine has been researched along with Necrosis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, T; Hiromatsu, K; Ishida, H; Kobayashi, N; Nimura, Y; Takano, M; Yoshikai, Y | 1 |
Allred, DV; Bell, JD; Burton, GF; Nielson, KH; O'Neill, KL; Olsen, CA | 1 |
Koike, T; Mitsui, C; Ninomiya, T; Sakai, K | 1 |
Ebbesen, P | 1 |
Ishii, K; Kusano, S; Matama, S; Matsuki, S; Shibata, H; Sugimoto, M | 1 |
Honda, Y; Kurebayashi, Y | 1 |
Inagaki, M; Kakisaka, A; Kasai, S; Mito, M; Suzuki, Y | 1 |
Kakisaka, A; Kasai, S; Mito, M | 1 |
8 other study(ies) available for bucladesine and Necrosis
Article | Year |
---|---|
IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Bucladesine; Chemical and Drug Induced Liver Injury; Female; In Vitro Techniques; Interleukin-10; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Necrosis; Propionibacterium acnes | 1995 |
Susceptibility of S49 lymphoma cell membranes to hydrolysis by secretory phospholipase A(2) during early phase of apoptosis.
Topics: Animals; Apoptosis; Bucladesine; Cell Membrane; Cell Membrane Permeability; Dexamethasone; Hot Temperature; Ionophores; Necrosis; Phospholipases A; Staining and Labeling; T-Lymphocytes; Thapsigargin; Time Factors; Tumor Cells, Cultured | 2000 |
Involvement of TLCK-sensitive serine protease in colchicine-induced cell death of sympathetic neurons in culture.
Topics: Animals; Animals, Newborn; Apoptosis; Bucladesine; Caspase 3; Caspases; Cells, Cultured; Colchicine; Enzyme Inhibitors; Immunohistochemistry; Microscopy, Electron; Microtubule Proteins; Necrosis; Nervous System; Neurons; Neuroprotective Agents; Potassium; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Serine Proteinase Inhibitors; Signal Transduction; Superior Cervical Ganglion; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone | 2001 |
Myocardial degeneration in mice treated with dibutyryl cyclic AMP and/or theophylline.
Topics: Animals; Bucladesine; Cardiomyopathies; Female; Leukemia, Experimental; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Myocardium; Necrosis; Theophylline | 1976 |
Is necrosis induction therapy relevant to hepatocellular carcinoma? Prognostic evaluation viewed from necrosing feature in HCC occluding the main portal vein after treatment with DBcAMP and MMC.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Necrosis; Portal Vein; Prognosis; Radiography; Survival Analysis | 1992 |
Protection by 16,16-dimethyl prostaglandin E2 and dibutyryl cyclic AMP against complement-mediated hepatic necrosis in rats.
Topics: Animals; Bucladesine; Complement System Proteins; Cyclic AMP; Liver; Male; Necrosis; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains | 1991 |
[Protective effects of DBcAMP on ischemic liver failure in dogs].
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Bucladesine; Dogs; Infusions, Intravenous; Ischemia; Liver; Necrosis; Regional Blood Flow | 1990 |
[Protective effects of DBcAMP on acute liver failure induced by D-galactosamine in rats].
Topics: Acute Disease; Adenosine Triphosphate; Animals; Blood Glucose; Bucladesine; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Circulation; Liver Diseases; Liver Function Tests; Male; Necrosis; Rats; Rats, Inbred Strains | 1989 |